Stock-based compensation increased 107.5%
Stock-based compensation changed +107.5% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Stock-based compensation changed +107.5% from the comparable as-filed period.
Debt / revenue changed +1478 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed -599 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Research & development changed +37.1% from the comparable as-filed period.
Operating cash flow changed +9.1% from the comparable as-filed period.
Receivables / revenue changed +303 basis points from the comparable as-filed period.
Capital expenditure changed -17.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed +46 basis points from the comparable as-filed period.
Free-cash-flow margin changed +38 basis points from the comparable as-filed period.
R&D / revenue changed -13 basis points from the comparable as-filed period.
Cash / debt changed -27 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Capex / revenue changed -206 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cash / debt changed +333 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed -378 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Debt / revenue changed -2858 basis points from the comparable as-filed period.
Stock-based compensation changed +44.7% from the comparable as-filed period.
Gross margin changed +83 basis points from the comparable as-filed period.
Receivables / revenue changed +392 basis points from the comparable as-filed period.
Free-cash-flow proxy changed -8.9% from the comparable as-filed period.
Operating cash flow changed -1.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed -172 basis points from the comparable as-filed period.
Research & development changed +13.8% from the comparable as-filed period.
SBC / revenue changed +7 basis points from the comparable as-filed period.
Current long-term debt changed +5.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capital expenditure changed +3.2% from the comparable as-filed period.
R&D / revenue changed -16 basis points from the comparable as-filed period.
Net debt changed -0.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.